Free Trial

Marlowe (LON:MRL) Stock Price Up 1.2% - Still a Buy?

Marlowe logo with Industrials background

Marlowe plc (LON:MRL - Get Free Report) traded up 1.2% on Friday . The stock traded as high as GBX 330 ($4.14) and last traded at GBX 328 ($4.11). 141,426 shares changed hands during trading, a decline of 77% from the average session volume of 606,029 shares. The stock had previously closed at GBX 324 ($4.06).

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on MRL shares. Royal Bank of Canada reaffirmed an "outperform" rating and issued a GBX 690 ($8.65) target price on shares of Marlowe in a report on Thursday, August 1st. Berenberg Bank restated a "buy" rating and issued a GBX 710 ($8.90) price objective on shares of Marlowe in a research note on Wednesday, August 21st.

Read Our Latest Stock Report on Marlowe

Marlowe Trading Up 1.2 %

The company has a current ratio of 1.24, a quick ratio of 0.80 and a debt-to-equity ratio of 58.99. The company has a 50 day moving average of GBX 357.65 and a 200 day moving average of GBX 434.09. The firm has a market cap of £287.69 million, a price-to-earnings ratio of -2,342.86 and a beta of 0.44.

Insider Buying and Selling

In other Marlowe news, insider Peter M. R. Gaze acquired 15,000 shares of Marlowe stock in a transaction on Friday, September 27th. The shares were bought at an average price of GBX 309 ($3.87) per share, with a total value of £46,350 ($58,104.55). 25.30% of the stock is currently owned by corporate insiders.

About Marlowe

(Get Free Report)

Marlowe plc provides compliance services and software in the United Kingdom. The company operates in two segments, Governance, Risk and Compliance; and Testing, and Inspection and Certification. It offers health and safety consultancy, risk and audit assessments, environmental, contractor management, and training services; and health and safety support services.

Recommended Stories

Should you invest $1,000 in Marlowe right now?

Before you consider Marlowe, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marlowe wasn't on the list.

While Marlowe currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines